Ask AI

Interactive Case Challenges

Share

Program Content

Activities

  • CDK4/6 Inhibitors HR Positive HER2 Negative EBC
    Case Challenge: Optimizing Patient–Provider Communication About CDK4/6 Inhibitors for Treatment of HR+/HER2- EBC
    Case Challenge
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 22, 2026

    Expires: November 21, 2026

  • CDK46 persistence
    Case Challenge: Improving Treatment Adherence and Persistence to CDK4/6 Inhibitor Treatment of HR+/HER2- EBC
    Case Challenge
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 21, 2026

    Expires: January 20, 2027

  • CDK4/6i Selection
    Case Challenge: Optimizing Adjuvant Therapy for a 39-Year-Old Premenopausal Woman With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
    Case Challenge
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 31, 2026

    Expires: February 28, 2027

Provided by

ProCE Banner

Provided by National Comprehensive Cancer Network in collaboration with Decera Clinical Education.

Supporters

This activity is supported by educational grants from Lilly and Novartis.

Lilly

Novartis

Partners

Decera Clinical Education

ProCE Banner